SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

BEAM.O (BEAM.O) News

Follow BEAM.O (BEAM.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BEAM.O Asset market Sector Markets 90 days 1 Updated Oct 13, 2026, 11:06 AM UTC Open live news feed
L Beam Therapeutics reports initial Phase 1/2 data for BEAM — 301 in glycogen storage disease type Ia trial Beam Therapeutics flagged initial Phase 1/2 results for BEAM-301 in glycogen storage disease type Ia for presentation at ESGCT. Data showed signs of restored patients’ ability to maintain glucose levels following a singl NEWS | Oct 13, 2026, 11:06 AM UTC